Back to Search
Start Over
Cytoplasmic-membrane anchoring of a class A beta-lactamase and its capacity in manifesting antibiotic resistance.
- Source :
-
Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2007 Aug; Vol. 51 (8), pp. 2937-42. Date of Electronic Publication: 2007 May 14. - Publication Year :
- 2007
-
Abstract
- Bacterial beta-lactamases are the major causes of resistance to beta-lactam antibiotics. Three classes of these enzymes are believed to have evolved from ancestral penicillin-binding proteins (PBPs), enzymes responsible for bacterial cell wall biosynthesis. Both beta-lactamases and PBPs are able to efficiently form acyl-enzyme species with beta-lactam antibiotics. In contrast to beta-lactamases, PBPs are unable to efficiently turn over antibiotics and therefore are susceptible to inhibition by beta-lactam compounds. Although both PBPs and gram-negative beta-lactamases operate in the periplasm, PBPs are anchored to the cytoplasmic membrane, but beta-lactamases are not. It is believed that beta-lactamases shed the membrane anchor in the course of evolution. The significance of this event remains unclear. In an attempt to demonstrate any potential influence of the membrane anchor on the overall biological consequences of beta-lactamases, we fused the TEM-1 beta-lactamase to the C-terminal membrane-anchor of penicillin-binding protein 5 (PBP5) of Escherichia coli. The enzyme was shown to express well in E. coli and was anchored to the cytoplasmic membrane. Expression of the anchored enzyme did not result in any changes in antibiotic resistance pattern of bacteria or growth rates. However, in the process of longer coincubation, the organism that harbored the plasmid for the anchored TEM-1 beta-lactamase lost out to the organism transformed by the plasmid for the nonanchored enzyme over a period of 8 days of continuous growth. The effect would appear to be selection of a variant that eliminates the problematic protein through elimination of the plasmid that encodes it and not structural or catalytic effects at the protein level. It is conceivable that an evolutionary outcome could be the shedding of the sequence for the membrane anchor or alternatively evolution of these enzymes from nonanchored progenitors.
- Subjects :
- Anti-Bacterial Agents pharmacology
Escherichia coli enzymology
Escherichia coli growth & development
Escherichia coli metabolism
Microbial Sensitivity Tests
Penicillin-Binding Proteins genetics
Plasmids
beta-Lactamases genetics
beta-Lactams pharmacology
Cell Membrane metabolism
Escherichia coli drug effects
Penicillin-Binding Proteins metabolism
beta-Lactam Resistance
beta-Lactamases metabolism
Subjects
Details
- Language :
- English
- ISSN :
- 0066-4804
- Volume :
- 51
- Issue :
- 8
- Database :
- MEDLINE
- Journal :
- Antimicrobial agents and chemotherapy
- Publication Type :
- Academic Journal
- Accession number :
- 17502412
- Full Text :
- https://doi.org/10.1128/AAC.00011-07